QA: Niagen Bioscience Inc in us_medicinal_products/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001386570_2025_Niagen_Bioscience_Inc.pdf

Logs

Graph

Absolute values for 0001386570, Niagen Bioscience Inc

  xvar xval
0 LiabilitiesNoncurrent 1,657,000
1 LiabilitiesCurrent 17,948,000
2 remainder_Liabilities 2,579,000
3 AssetsCurrent 64,102,000
4 AssetsNoncurrent 2,098,000
5 PropertyPlantAndEquipmentNet 1,719,000
6 Goodwill 359,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 85,855,000
9 ResearchAndDevelopmentExpense 6,016,000
10 remainder_Expenses 305,000
11 remainder_Revenues 99,597,000
12 remainder_NetIncome 1,129,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 22,184,000
1 Assets 68,278,000
2 Expenses 92,176,000
3 Revenues 99,597,000
4 StockholdersEquity 46,094,000
5 NetIncome 8,550,000
6 ComprehensiveNetIncome 8,550,000
7 BaseVar 141,682,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.59
9 EconomicCapitalRatio 2.07

Edgar->Model Mapping

Feature Distribution

Change over Time